Hitesh C. Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hitesh C. Patel has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
Carl Hayward
NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom
7 shared publications- Justin A. Mariani
Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia
7 shared publications - Carlo Di Mario
Structural Interventional Cardiology, Department of Clinical and Experimental Medicine, Careggi University Hospital, Florence, Italy
3 shared publications - Shane Nanayakkara
Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia
3 shared publications Alexander R. Lyon
NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom
2 shared publicationsCarlo Di Mario
NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom
2 shared publications
Latest Publications
- 29 July 2023
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 32, S119
Multidisciplinary Early Access Care Model to Optimise Outcomes in Atrial Fibrillation Management
- 29 July 2023
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 32, S119
Multidisciplinary Early Access Care Model to Optimise Outcomes in Atrial Fibrillation Management
- Open Access
- 18 May 2023
- Published by Elsevier in Indian Pacing and Electrophysiology Journal
- Vol. 23 (4) , 126-129
Subcutaneous defibrillator use with unipolar pacemakers: Cautiously possible
- 18 May 2023
- Published by Elsevier in Indian Pacing and Electrophysiology Journal
- Vol. 23 (4) , 126-129
Open AccessSubcutaneous defibrillator use with unipolar pacemakers: Cautiously possible
- 1 October 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (Supplement)
Long-term implications of pacemaker insertion in younger adults: a single centre experience
Background: The long-term implications of pacemaker insertion in younger adults are poorly described in the literature. Methods: We performed a retrospective analysis of consecutive younger adult patients (18–50 years) undergoing pacemaker implantation at a quaternary hospital between 1986–2020. Defibrillators and cardiac resynchronisation therapy devices were excluded. All clinical records, pacemaker checks and echocardiograms were reviewed. Results: 81 patients (39.5±9.6 years, 53% male) underwent pacemaker implantation. Indications were complete heart block (41%), sinus node dysfunction (33%), high grade AV block (11%) and tachycardia-bradycardia syndrome (7%). During a median 7.6 (IQR=0.6–14.8) years follow-up, 9 patients (11%) developed 13 late device-related complications (generator or lead malfunction requiring reoperation (n=11), device infection (n=1) and pocket revision (n=1)). Five of these patients were 10%) was observed in 14 patients (17%) and 7 of these patients required subsequent biventricular upgrade. Furthermore, 4 patients (5%) developed new tricuspid regurgitation (≥ moderate-severe). Of 69 patients with available long-term pacing data, minimal pacemaker utilisation (pacing <5% at all checks) was observed in 13 (19%) patients. Conclusions: Pacemaker insertion in younger adults has significant long-term implications. Clinicians should carefully consider pacemaker insertion in this cohort given risk of device-related complications, potential for device under-utilisation and issues related to lead longevity. In addition, patients require close follow-up for development of structural abnormalities and arrhythmias. Funding Acknowledgement: Type of funding sources: None.
- 1 October 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (Supplement)
Long-term implications of pacemaker insertion in younger adults: a single centre experience
Background: The long-term implications of pacemaker insertion in younger adults are poorly described in the literature. Methods: We performed a retrospective analysis of consecutive younger adult patients (18–50 years) undergoing pacemaker implantation at a quaternary hospital between 1986–2020. Defibrillators and cardiac resynchronisation therapy devices were excluded. All clinical records, pacemaker checks and echocardiograms were reviewed. Results: 81 patients (39.5±9.6 years, 53% male) underwent pacemaker implantation. Indications were complete heart block (41%), sinus node dysfunction (33%), high grade AV block (11%) and tachycardia-bradycardia syndrome (7%). During a median 7.6 (IQR=0.6–14.8) years follow-up, 9 patients (11%) developed 13 late device-related complications (generator or lead malfunction requiring reoperation (n=11), device infection (n=1) and pocket revision (n=1)). Five of these patients were 10%) was observed in 14 patients (17%) and 7 of these patients required subsequent biventricular upgrade. Furthermore, 4 patients (5%) developed new tricuspid regurgitation (≥ moderate-severe). Of 69 patients with available long-term pacing data, minimal pacemaker utilisation (pacing <5% at all checks) was observed in 13 (19%) patients. Conclusions: Pacemaker insertion in younger adults has significant long-term implications. Clinicians should carefully consider pacemaker insertion in this cohort given risk of device-related complications, potential for device under-utilisation and issues related to lead longevity. In addition, patients require close follow-up for development of structural abnormalities and arrhythmias. Funding Acknowledgement: Type of funding sources: None.
- Open Access
- 8 August 2020
- Published by Wiley in Journal of Pharmacy Practice and Research
- Vol. 50 (4) , 366-368
Contemporary trends in antiplatelet prescription in Australia
- 8 August 2020
- Published by Wiley in Journal of Pharmacy Practice and Research
- Vol. 50 (4) , 366-368
Open AccessContemporary trends in antiplatelet prescription in Australia
- Open Access
- 1 December 2019
- Published by Elsevier in JACC: Case Reports
- Vol. 1 (5) , 713-717
Large Left Ventricular Outflow Tract Pseudoaneurysm Closed Percutaneously From a Novel Apical Approach
- 1 December 2019
- Published by Elsevier in JACC: Case Reports
- Vol. 1 (5) , 713-717
Open AccessLarge Left Ventricular Outflow Tract Pseudoaneurysm Closed Percutaneously From a Novel Apical Approach
- Open Access
- 3 September 2019
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 27 (19) , 2180-2182
Non-invasive blood pressure monitoring underestimates hypertensive response to exercise in suspected heart failure with preserved ejection fraction
- 3 September 2019
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 27 (19) , 2180-2182
Open AccessNon-invasive blood pressure monitoring underestimates hypertensive response to exercise in suspected heart failure with preserved ejection fraction
- 9 October 2018
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 20 (12) , 1744-1745
Exercise Training in Heart Failure: A Long Way to go Yet
- 9 October 2018
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 20 (12) , 1744-1745
Exercise Training in Heart Failure: A Long Way to go Yet
- 5 December 2017
- Published by Wiley in Internal Medicine Journal
- Vol. 48 (4) , 427-432
Trends in outpatient anti‐arrhythmic prescriptions for atrial fibrillation and left atrial ablation in Australia: 1997–2016
Background: An important aspect of atrial fibrillation (AF) management is the decision whether to adopt a rate or rhythm control strategy. Options for the latter include oral anti‐arrhythmic drugs (AAD) or catheter ablation.Aim: To describe the trends in rhythm control for AF in Australia between 1997 and 2016.Methods: We conducted a retrospective study using prospectively collected data between 1997 and 2016 from the Pharmaceutical Benefit Scheme and Medicare Benefit Schedule websites, which, respectively, contain information pertaining to public AAD prescriptions and rebatable AF ablation procedures performed in Australia.Results: Sotalol and amiodarone remain the most commonly prescribed AAD in Australia, although their use is decreasing. Rates of catheter ablation for AF continue to rise annually with a 48‐fold increase from 71 to 3480 since 1997.Conclusion: A rhythm control strategy is frequently utilised for AF management in Australia. Consistent with international guidelines which advocate safety over efficacy when choosing a rhythm control strategy, the prescriptions of amiodarone have been consistently decreasing since 2002, whereas sotalol and flecainide prescriptions have largely increased, with a peak in 2015. Catheter ablation per capita has burgeoned 36‐fold.
- 5 December 2017
- Published by Wiley in Internal Medicine Journal
- Vol. 48 (4) , 427-432
Trends in outpatient anti‐arrhythmic prescriptions for atrial fibrillation and left atrial ablation in Australia: 1997–2016
Background: An important aspect of atrial fibrillation (AF) management is the decision whether to adopt a rate or rhythm control strategy. Options for the latter include oral anti‐arrhythmic drugs (AAD) or catheter ablation.Aim: To describe the trends in rhythm control for AF in Australia between 1997 and 2016.Methods: We conducted a retrospective study using prospectively collected data between 1997 and 2016 from the Pharmaceutical Benefit Scheme and Medicare Benefit Schedule websites, which, respectively, contain information pertaining to public AAD prescriptions and rebatable AF ablation procedures performed in Australia.Results: Sotalol and amiodarone remain the most commonly prescribed AAD in Australia, although their use is decreasing. Rates of catheter ablation for AF continue to rise annually with a 48‐fold increase from 71 to 3480 since 1997.Conclusion: A rhythm control strategy is frequently utilised for AF management in Australia. Consistent with international guidelines which advocate safety over efficacy when choosing a rhythm control strategy, the prescriptions of amiodarone have been consistently decreasing since 2002, whereas sotalol and flecainide prescriptions have largely increased, with a peak in 2015. Catheter ablation per capita has burgeoned 36‐fold.
- Open Access
- 8 November 2017
- Published by Springer Nature in Echo Research & Practice
- Vol. 4 (4) , K57-K60
An overlooked case of pacemaker-related heart failure
This case describes an iatrogenic cause of heart failure: the pacemaker syndrome. The diagnosis was initially overlooked but in retrospect could have easily been made by reviewing the rhythm strip recorded during the echocardiogram. The patient eventually received the correct treatment to restore atrioventricular synchrony and experienced rapid resolution to her disabling symptoms. Learning points: New-onset heart failure following a pacemaker implant should be evaluated with an echocardiogram. Alongside pacing-induced left ventricular systolic dysfunction and pacing wire-related cardiac valve disruption, pacemaker syndrome should be considered. Interpreting a good-quality (showing both P waves and QRS complexes) rhythm strip can greatly aid in the diagnosis of pacemaker syndrome.
- 8 November 2017
- Published by Springer Nature in Echo Research & Practice
- Vol. 4 (4) , K57-K60
Open AccessAn overlooked case of pacemaker-related heart failure
This case describes an iatrogenic cause of heart failure: the pacemaker syndrome. The diagnosis was initially overlooked but in retrospect could have easily been made by reviewing the rhythm strip recorded during the echocardiogram. The patient eventually received the correct treatment to restore atrioventricular synchrony and experienced rapid resolution to her disabling symptoms. Learning points: New-onset heart failure following a pacemaker implant should be evaluated with an echocardiogram. Alongside pacing-induced left ventricular systolic dysfunction and pacing wire-related cardiac valve disruption, pacemaker syndrome should be considered. Interpreting a good-quality (showing both P waves and QRS complexes) rhythm strip can greatly aid in the diagnosis of pacemaker syndrome.